About: Early Detection and Assessment of Covid-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Early Detection and Assessment of Covid-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Early Detection and Assessment of Covid-19
Creator	Kozlakidis, Zisis Afonso, Ana Asif, Hafiz Abdul, Hafiz Ahmad, Fayyaz Hashmi, Sattar Mohiuddin, Italy Roma, Pietro
source	Medline; PMC; WHO
abstract	Background: Since the Covid-19 global pandemic emerged, developing countries have been facing multiple challenges over its diagnosis. We aimed to establish a relationship between the signs and symptoms of COVID-19 for early detection and assessment to reduce the transmission rate of SARS-Cov-2. Methods: We collected published data on the clinical features of Covid-19 retrospectively and categorized them into physical and blood biomarkers. Common features were assigned scores by the Borg scoring method with slight modifications and were incorporated into a newly-developed Hashmi-Asif Covid-19 assessment Chart. Correlations between signs and symptoms with the development of Covid-19 was assessed by Pearson correlation and Spearman Correlation coefficient (rho). Linear regression analysis was employed to assess the highest correlating features. The frequency of signs and symptoms in developing Covid-19 was assessed through Chi-square test two tailed with Cramer's V strength. Changes in signs and symptoms were incorporated into a chart that consisted of four tiers representing disease stages. Results: Data from 10,172 Covid-19 laboratory confirmed cases showed a correlation with Fever in 43.9% (P = 0.000) cases, cough 54.08% and dry mucus 25.68% equally significant (P = 0.000), Hyperemic pharyngeal mucus membrane 17.92% (P = 0.005), leukopenia 28.11% (P = 0.000), lymphopenia 64.35% (P = 0.000), thrombopenia 35.49% (P = 0.000), elevated Alanine aminotransferase 50.02% (P = 0.000), and Aspartate aminotransferase 34.49% (P = 0.000). The chart exhibited a maximum scoring of 39. Normal tier scoring was ≤ 12/39, mild state scoring was 13–22/39, and star values scoring was ≥7/15; this latter category on the chart means Covid-19 is progressing and quarantine should be adopted. Moderate stage scored 23–33 and severe scored 34–39 in the chart. Conclusion: The Hashmi-Asif Covid-19 Chart is significant in assessing subclinical and clinical stages of Covid-19 to reduce the transmission rate.
has issue date	2020-06-09(xsd:dateTime)
bibo:doi	10.3389/fmed.2020.00311
bibo:pmid	32582748
has license	cc-by
sha1sum (hex)	240abad92e610caab36f596b437c111e6cbe7099
schema:url	https://doi.org/10.3389/fmed.2020.00311
resource representing a document's title	Early Detection and Assessment of Covid-19
has PubMed Central identifier	PMC7296153
has PubMed identifier	32582748
schema:publication	Front Med (Lausanne)
resource representing a document's body	covid:240abad92e610caab36f596b437c111e6cbe7099#body_text
is schema:about of	named entity 'ASSESSMENT' named entity 'COVID' named entity 'global pandemic' named entity 'viral pneumonia' named entity 'leukopenia' named entity 'Asymptomatic' named entity 'Covid' named entity 'signs and symptoms' named entity 'Cough' named entity 'infection' named entity 'Covid' named entity 'Covid' named entity 'IBM' named entity 'healthcare systems' named entity 'enlarged lymph nodes' named entity 'RT-PCR' named entity 'diabetes' named entity 'fatigue' named entity 'vomiting' named entity 'retrospective studies' named entity 'mechanical ventilation' named entity 'correlation' named entity 'thrombocytopenia' named entity 'T-lymphocytes' named entity 'SARS-Cov-2' named entity 'correlation' named entity 'incubation period' named entity 'ventricular tachycardia' named entity 'biomarkers' named entity 'Covid' named entity 'RT-PCR' named entity 'RT-PCR' named entity 'Covid' named entity 'leukopenia' named entity 'Influenza' named entity 'SARS-Cov-2' named entity 'fever' named entity 'clinical features' named entity 'H3N2' named entity 'coughing' named entity 'epithelial cells' named entity 'signs and symptoms' named entity 'pathology' named entity 'Covid' named entity 'Covid' named entity 'infection' named entity 'cardiomyopathies' named entity 'prospective study' named entity 'aminotransferases' named entity 'pneumothorax' named entity 'signs and symptoms' named entity 'Borg Scale' named entity 'H5N1' named entity 'correlation' named entity 'infection' named entity 'lymphopenia' named entity 'Covid' named entity 'SARS' named entity 'misdiagnosis' named entity 'symptom' named entity 'abdominal discomfort' named entity 'Covid' named entity 'Covid-19' named entity 'aminotransferases' named entity 'epithelial' named entity 'Covid' named entity 'SARS-Cov-2' named entity 'signs and symptoms' named entity 'epidemic' named entity 'Covid' named entity 'Persistent cough' named entity 'H1N1' named entity 'mucus' named entity 'Covid'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software